4Ludwig H,Cohen AM,Polliack A. Interferon-alpha for induction and maintenance in multiple myeloma:results of two multicenter randomized trials and summary of other studies[J].Annals of Oncology,1995,(05):467-476.
5Palumbo A,Giaccone L,Bertola A. Low dose thalidomide plus dexzmet hasone is an effective salvage therapy for advanced myeloma[J].Hematological Oncology,2001,(04):399-403.doi:10.1016/j.jbiotec.2010.01.012.
6Lelen X,Magro L,Fawaz A. Efficacy of a low dose of thalidomidein advanced multiple mueloma[J].Blood,2002,(04):1519-1520.
7Johnston RE,Abdalla SH. Thalidomide in low dose is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia[J].Leukemia and Lymphoma,2002,(02):3512-3541.doi:10.1080/10428190290006143.
8Sung B,Kunnumakkara AB,Sethi G. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model[J].Molecular Cancer Therapeutics,2009,(04):959-970.doi:10.1158/1535-7163.MCT-08-0905.
9Hatcher H,Planalp R,Cho J. Curcumin:from ancient medicine to current clinical trials[J].Cellular and Molecular Life Sciences,2008,(11):1631-1652.doi:10.1007/s00018-008-7452-4.
10Hayashi T,Hideshima T,Akiyama M. Arsenic trioxide inhibit growth of human multiple myeloma cells in the bone marrow microen-vironment[J].Molecular Cancer Therapeutics,2002,(10):851-860.doi:10.1140/epjc/s10052-011-1597-2.
